Published February 27, 2026 | Version v1

A COMPREHENSIVE REVIEW ON: FLOATING MICROBEADS FOR GASTRORETENTIVE DRUG DELIVERY

  • 1. Student, PDEA's Seth Govind Raghunath Sable College of Pharmacy, Saswad, Pune.
  • 2. Assistant Prof., Department of Pharmaceutics, PDEA's Seth Govind Raghunath Sable College of Pharmacy, Saswad, Pune.
  • 3. HOD, Department of Pharmaceutics, PDEA's Seth Govind Raghunath Sable College of Pharmacy, Saswad, Pune.

Description

The purpose of floating microbeads is to enhance the duration of gastric retention. These floating drug delivery systems have a lower bulk density than gastric juice, allowing them to remain buoyant on the gastric fluid for extended periods without affecting the gastric-emptying rate, thereby improving bioavailability. Gastro-retentive microbeads are particularly advantageous for the sustained or delayed release of oral formulations, offering flexibility in blending to achieve different release profiles, minimizing dosage risks due to their consistent and brief gastric retention time. This review aims to explore the literature on floating devices, techniques, the selection of appropriate or unsuitable drug candidates for GRDDS, low-density polymers that enable flotation on gastric fluid, processes, and the evaluation and application of floating microbeads.

Files

5 WJPSR 2077.pdf

Files (1.1 MB)

Name Size Download all
md5:6f77bcb74c3639b5c95033b0a3e96ad5
1.1 MB Preview Download

Additional details

References

  • 1. Kotreka, U. K., & Adeyeye, M. C., Gastro-retentive floating drug-delivery systems: a critical review, Critical Reviews™ in Therapeutic Drug Carrier Systems, 2011; 28(1): 47–99.
  • 2. Niharika, M. G., Krishnamoorthy, K., & Akkala, M., Overview on floating drug delivery system, International Journal of Applied Pharmaceutics, 2018; 10(6): 65.
  • 3. Soppimath, K. S., Kulkarni, A. R., Rudzinski, W. E., & Aminabhavi, T. M., Microspheres as floating drug-delivery systems to increase gastric retention of drugs, Drug Metabolism Reviews, 2001; 33(2): 149–160.
  • 4. Arora, S., Ali, J., Ahuja, A., Khar, R. K., & Baboota, S., Floating drug delivery systems: a review, AAPS PharmSciTech, 2005; 6(3): E372–E390.
  • 5. Chandel, A., Chauhan, K., Parashar, B., Kumar, H., & Arora, S., Floating drug delivery systems: a better approach, International Current Pharmaceutical Journal, 2012; 1(5): 119–127.
  • 6. Adibkia, K., Hamedeyazdan, S., & Javadzadeh, Y., Drug release kinetics and physicochemical characteristics of floating drug delivery systems, Expert Opinion on Drug Delivery, 2011; 8(7): 891–903.
  • 7. Kaushik, A., Tiwari, A., & Gaur, A., Role of excipients and polymeric advancements in preparation of floating drug delivery systems, International Journal of Pharmaceutical Investigation, 2015; 5(1): 1.
  • 8. Waqar, M. A., Mubarak, N., Khan, A. M., Khan, R., Shaheen, F., & Shabbir, A., Advanced polymers and recent advancements on gastroretentive drug delivery system: a comprehensive review, Journal of Drug Targeting, 2024; 32(6): 655–671.
  • 9. Kumar, M., & Kaushik, D., An overview on various approaches and recent patents on gastroretentive drug delivery systems, Recent Patents on Drug Delivery & Formulation, 2018; 12(2): 84–92.
  • 10. Sharma, A., Puri, V., Kakkar, V., & Singh, I., Formulation and evaluation of silymarin-loaded chitosan-montmorilloite microbeads for the potential treatment of gastric ulcers, Journal of Functional Biomaterials, 2018; 9(3): 52.
  • 11. Pedroso-Santana, S., & Fleitas-Salazar, N., Ionotropic gelation method in the synthesis of nanoparticles/microparticles for biomedical purposes, Polymer International, 2020; 69(5): 443–447.
  • 12. Henao, E., Delgado, E., Contreras, H., & Quintana, G., Polyelectrolyte complexation versus ionotropic gelation for chitosan-based hydrogels with carboxymethylcellulose, carboxymethyl starch, and alginic acid, International Journal of Chemical Engineering, 2018; 2018: 1–12.
  • 13. Obireddy, S. R., Chintha, M., Kashayi, C. R., Venkata, K. R. K. S., & Subbarao, S. M. C., Gelatin-coated dual cross-linked sodium alginate/magnetite nanoparticle microbeads for controlled release of doxorubicin, ChemistrySelect, 2020; 5(33): 10276–10284.
  • 14. Moinuddin, S., M, P., G, S., Ramya, P., Sree, K., & K, K., A review on micro beads: formulation, technological aspects, and extraction, GSC Biological and Pharmaceutical Sciences, 2024; 26(2): 059–066.
  • 15. Chakraborty, S., Khandai, M., Sharma, A., Khanam, N., Patra, C., Dinda, S., & Sen, K., Preparation, in vitro and in vivo evaluation of algino-pectinate bioadhesive microspheres: an investigation of the effects of polymers using multiple comparison analysis, Acta Pharmaceutica, 2010; 60(3): 255–266.
  • 16. Reddy, O. S., Subha, M., Jithendra, T., Madhavi, C., & Rao, K. C., Fabrication and characterization of smart karaya gum/sodium alginate semi-IPN microbeads for controlled release of D-penicillamine drug, Polymers and Polymer Composites, 2020; 29(3): 163–175.
  • 17. Pal, D., & Nayak, A. K., Development, optimization, and anti-diabetic activity of gliclazide-loaded alginate–methyl cellulose mucoadhesive microcapsules, AAPS PharmSciTech, 2011; 12(4): 1431–1441.
  • 18. Iwamoto, S., Nakagawa, K., Sugiura, S., & Nakajima, M., Preparation of gelatin microbeads with a narrow size distribution using microchannel emulsification, AAPS PharmSciTech, 2002; 3(3): 72–76.
  • 19. Khan, Z., Abourehab, M. A. S., Parveen, N., Kohli, K., & Kesharwani, P., Recent advances in microbeads-based drug delivery system for achieving controlled drug release, Journal of Biomaterials Science, Polymer Edition, 2022; 34(4): 541–564.
  • 20. Yahoum, M. M., Toumi, S., Tahraoui, H., Lefnaoui, S., Kebir, M., Amrane, A., Assadi, A. A., Zhang, J., & Mouni, L., Formulation and evaluation of xanthan gum microspheres for the sustained release of metformin hydrochloride, Micromachines, 2023; 14(3): 609.
  • 21. Essifi, K., Lakrat, M., Berraaouan, D., Fauconnier, M.-L., El Bachiri, A., & Tahani, A., Optimization of gallic acid encapsulation in calcium alginate microbeads using Box–Behnken experimental design, Polymer Bulletin, 2020; 78(10): 5789–5814.
  • 22. Dhawan, S., Singla, A. K., & Sinha, V. R., Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods, AAPS PharmSciTech, 2004; 5(4): 122–128.
  • 23. Kulkarni, R. V., Mutalik, S., Mangond, B. S., & Nayak, U. Y., Novel interpenetrated polymer network microbeads of natural polysaccharides for modified release of water-soluble drug: in-vitro and in-vivo evaluation, Journal of Pharmacy and Pharmacology, 2012; 64(4): 530–540.
  • 24. El Nabarawi, M. A., Teaima, M. H., Abd El-Monem, R. A., El Nabarawy, N. A., & Gaber, D. A., Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of mebeverine HCl, Drug Design, Development and Therapy, 2017; 11(1): 1081–1093.
  • 25. Kiran HC, Venkatesh DN and Kumar RR, Formulation and characterization of sustained release microbeads loaded with zaltoprofen, IJAP, 2019; 11(5): 173–180.
  • 26. Nayak AK, Khatua S, Hasnain MS, Sen KK, Development of diclofenac sodium-loaded alginate-PVP K 30 microbeads using central composite design, Daru, 2011; 19(5): 356–366.
  • 27. Dhote V, Dhote K and Mishra DK, Formulation and characterization of microbeads as a carrier for the controlled release of rioprostil, Asian Journal of Pharmacy and Pharmacology, 2015; 1(1): 27–32.
  • 28. Victor Badron and Pavel Gurikov, A continuous approach to the emulsion gelation method for the production of aerogel microparticle, CSPEA, 2019; 566: 58–69.
  • 29. Sherina VM, Santhi K and Sajeeth CI, Formulation and evaluation of sodium alginate microbeads as a carrier for the controlled release of nifedipine, IJPCS, 2012; 1: 699–710.